secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Therapeutics, Inc. (VYGR)
CIK:        0001640266
Form:       8-K
Filed at:   2022-12-14T23:59:59+00:00
Accession:  0001104659-22-126797
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Voyager Therapeutics appoints Grace E. Colón, Ph.D. to board of directors, effective Jan 1, 2023
--------------------------------------------------------------------------------

- Grace E. Colón appointed as Class I director; term runs until 2025 annual meeting.
- Annual cash retainer of $40,000 for board service; $6,000 for Compensation Committee membership.
- Initial option grant of 44,000 shares vesting quarterly over four years; annual option of 22,000 shares thereafter.
- Dr. Colón also serves as Executive Chair of ProterixBio and director of CareDx; no family relationships with officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1640266/000110465922126797/0001104659-22-126797-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1640266/000110465922126797/tm2232536d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-126797

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer